中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
14期
14-16
,共3页
非酒精性脂肪性肝炎%肝郁脾虚%升降汤%临床观察
非酒精性脂肪性肝炎%肝鬱脾虛%升降湯%臨床觀察
비주정성지방성간염%간욱비허%승강탕%림상관찰
Non-alcoholic steatohepatitis%Ganyu Pixu%The shengjiang decoction%Clinical observation
目的：评价升降汤治疗肝郁脾虚型非酒精性脂肪性肝炎的临床疗效。方法：选择非酒精性脂肪性肝炎肝郁脾虚型患者80例，随机分为两组，其中升降汤组40例，易善复组40例，疗程为12周。观察两组治疗后中医证候、肝功能、血脂及B超结果，评价其疗效。结果：升降汤组中医证候改善总有效率为85.00%，易善复组为67.50%，差异有统计学意义（P<0.01）。两组治疗后肝功能、血脂较治疗前差异有统计学意义（P<0.01），组间治疗后比较差异有统计学意义（P<0.01）。治疗升降汤组B 超总改善率为87.50%，易善复组B超总改善率为75.00%，两组比较差异有统计学意义（P<0.05）。结论：升降汤对肝郁脾虚型非酒精性脂肪性肝炎患者有较好的治疗作用，其疗效优于易善复。
目的：評價升降湯治療肝鬱脾虛型非酒精性脂肪性肝炎的臨床療效。方法：選擇非酒精性脂肪性肝炎肝鬱脾虛型患者80例，隨機分為兩組，其中升降湯組40例，易善複組40例，療程為12週。觀察兩組治療後中醫證候、肝功能、血脂及B超結果，評價其療效。結果：升降湯組中醫證候改善總有效率為85.00%，易善複組為67.50%，差異有統計學意義（P<0.01）。兩組治療後肝功能、血脂較治療前差異有統計學意義（P<0.01），組間治療後比較差異有統計學意義（P<0.01）。治療升降湯組B 超總改善率為87.50%，易善複組B超總改善率為75.00%，兩組比較差異有統計學意義（P<0.05）。結論：升降湯對肝鬱脾虛型非酒精性脂肪性肝炎患者有較好的治療作用，其療效優于易善複。
목적：평개승강탕치료간욱비허형비주정성지방성간염적림상료효。방법：선택비주정성지방성간염간욱비허형환자80례，수궤분위량조，기중승강탕조40례，역선복조40례，료정위12주。관찰량조치료후중의증후、간공능、혈지급B초결과，평개기료효。결과：승강탕조중의증후개선총유효솔위85.00%，역선복조위67.50%，차이유통계학의의（P<0.01）。량조치료후간공능、혈지교치료전차이유통계학의의（P<0.01），조간치료후비교차이유통계학의의（P<0.01）。치료승강탕조B 초총개선솔위87.50%，역선복조B초총개선솔위75.00%，량조비교차이유통계학의의（P<0.05）。결론：승강탕대간욱비허형비주정성지방성간염환자유교호적치료작용，기료효우우역선복。
Objective:To evaluate clinical effects of the Shengjiang decoction on non-alcoholic steatohepatitis. Methods:80 cases of non-alcoholic steatohepatitis were randomly divided into the Shengjiang decoction group and the polyene phosphatidylcholine capsule group, each group for 40 cases. 12 weeks for a course. After the treatment, syndromes, liver function, blood lipids and type-B ultrasonic results in two groups were observed, and clinical effects in two groups were evaluated. Results:In the Shengjiang decoction group, the total efficiency was 85%, better than that in the polyene phosphatidylcholine capsule group (67.50%). The difference was statistically significant (P<0.01). After the treatment, liver function and blood lipids in each group were significantly different. The difference was statistically significant (P<0.01). Differences between two groups were statistically significant (P<0.01). In the Shengjiang decoction group, improvement of type-B ultrasonic was 87.50%, better than that in the polyene phosphatidylcholine capsule group (75.00%). The difference was statistically significant (P<0.05). Conclusion:The Shengjiang decoction was effective on non-alcoholic steatohepatitis, better than the polyene phosphatidylcholine capsule.
